Lv2
108 积分 2024-02-02 加入
Ozoralizumab: First Approval
1天前
待确认
Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials
1天前
已关闭
Ozoralizumab: first Nanobody® therapeutic for rheumatoid arthritis
1天前
已完结
Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
2天前
已关闭
Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
3天前
已完结
Ankylosing spondylitis: From pathogenesis to therapy
9天前
已完结
Role of TL1A in Inflammatory Autoimmune Diseases: A Comprehensive Review
9天前
已完结
Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells
15天前
已完结
Expression of Lgr5, a marker of intestinal stem cells, in colorectal cancer and its clinicopathological significance
16天前
已完结
The role of mivacurium in contemporary anesthesiology: a narrative review
21天前
已完结
皖公网安备34019202002308
